Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
11.11
+0.31 (2.87%)
Jan 30, 2025, 4:00 PM EST - Market closed
Emergent BioSolutions Employees
Emergent BioSolutions had 1,600 employees as of December 31, 2023. The number of employees decreased by 900 or -36.00% compared to the previous year.
Employees
1,600
Change (1Y)
-900
Growth (1Y)
-36.00%
Revenue / Employee
$703,438
Profits / Employee
-$130,500
Market Cap
601.99M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
EBS News
- 14 days ago - Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA) - GlobeNewsWire
- 16 days ago - Emergent BioSolutions: Stock Is A Likely Winner In 2025 - Seeking Alpha
- 16 days ago - Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals - GlobeNewsWire
- 17 days ago - Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola - GlobeNewsWire
- 22 days ago - Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - GlobeNewsWire
- 22 days ago - Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed) - GlobeNewsWire
- 2 months ago - SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook - Seeking Alpha
- 2 months ago - Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic - Seeking Alpha